Methylation not a frequent “second hit” in tumors with germline BRCA mutations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Methylation not a frequent “second hit” in tumors with germline BRCA mutations

Published:2009-04-02 Issue:4 Volume:8 Page:339-346
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Dworkin Amy M.,Spearman Andrew D.,Tseng Stephanie Y.,Sweet Kevin,Toland Amanda Ewart

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics(clinical),Oncology,Genetics

Link

http://link.springer.com/content/pdf/10.1007/s10689-009-9240-1.pdf

Reference29 articles.

1. Knudson AG (2001) Two genetic hits (more or less) to cancer. Nat Rev Cancer 1:157–162

2. Neuhausen SL, Marshall CJ (1994) Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res 54:6069–6072

3. Osorio A, de la Hoya M, Rodriguez-Lopez R et al (2002) Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer 99:305–309

4. Cornelis RS, Neuhausen SL, Johansson O et al (1995) High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCA1-linked families, The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer 13:201–210

5. Chenevix-Trench G, Healey S, Lakhani S et al (2006) Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 66:2019–2027

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer;Annals of Oncology;2024-04

2. BRCA1/2 Haploinsufficiency: Exploring the Impact of Losing one Allele;Journal of Molecular Biology;2024-01

3. Effects of a phthalate metabolite mixture on both normal and tumoral human prostate cells;Environmental Toxicology;2022-07-21

4. The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis;Antioxidants;2022-06-17

5. Genetic and epigenetic profiling of the BRCA1 / 2 genes in solitary ovarian cancer and multiple primary ovarian tumors;Pelvic Surgery and Oncology;2021-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3